Otizm Spektrum Bozukluğunda Sitokin ve BDNF Düzeyleri

Adams, J. B., Audhya, T., McDonough-Means, S, et al. (2011). Nutritional and metabolic status of children with autism vs neurotypical children, and the association with autism severity. Nutrition & Metabolism, 8, 34.

Al-Ayadhi, L. Y. (2012). Relationship between sonic hedgehog protein, brain-derived neurotrophic factor and oxidative stress in autism spectrum disorders. Neurochemical Research, 37, 394–400.

Al-Ayadhi, L. Y., & Mostafa, G. A. (2012). Elevated serum levels of interleukin-17A in children with autism. Journal of Neuroinflammation, 9, 158.

Angelidou, A., Asadi, S., Alysandratos, K. D., Karagkouni, A., Kourembanas, S., & Theoharides, T. C. (2012). Perinatal stress, brain inflammation and risk of autism: Review and proposal. BMC Pediatrics, 12, 89.

Archer, T., Fredriksson, A., Schütz, E., & Kostrzewa, R. M. (2011). Influence of physical exercise on neuroimmunological functioning and health: Aging and stress. Neurotoxicology Research, 20, 69–83.

Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I., & Van de Water, J. (2011). Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain, Behavior, and Immunity, 25, 40–45.

Baxter, A. J., Brugha, T. S., Erskine, H. E., Scheurer, R. W., Vos, T., & Scott, J. G. (2015). The epidemiology and global burden of autism spectrum disorders. Psychological Medicine, 45(3), 601–613.

Besedovsky, H., Del Rey, A., Sorkin, E., & Dinarello, C. A. (1986). Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science, 233, 652–654.

Blaylock, R. L., & Maroon, J. (2011). Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy: A unifying hypothesis. Surgical Neurology International, 2, 107.

Blaylock, R. L., & Maroon, J. (2012). Natural plant products and extracts that reduce immunoexcitotoxicity-associated neurodegeneration and promote repair within the central nervous system. Surgical Neurology International, 3, 19.

Bryn, V., Aass, H. C. D., Skjeldal, O. H., Isaksen, J. O., Saugstad, D., & Ormstad, H. (2017). Cytokine profile in autism spectrum disorders in children. Journal of Molecular Neuroscience, 61, 1–7.

Brynskikh, A., Warren, T., Zhu, J., & Kipnis, J. (2008). Adaptive immunity affects learning behavior in mice. Brain, Behavior, and Immunity, 22, 861–869.

Cacabelos, R., Franco-Maside, A., & Alvarez, X. A. (1991). Interleukin-1 in Alzheimer’s disease and multi-infarct dementia: Neuropsychological correlations. Methods and Findings in Experimental & Clinical Pharmacology, 13, 703–708.

Chez, M. G., & Guido‐Estrada, N. (2010). Immune therapy in autism: Historical experience and future directions with immunomodulatory therapy. Neurotherapeutics, 7, 293–301.

Courchesne, E., Mouton, P. R., Calhoun, M. E., Semendeferi, K., Ahrens-Barbeau, C., Hallet, M. J., Barnes, C. C., & Pierce, K. (2011). Neuron number and size in prefrontal cortex of children with autism. JAMA, 306, 2001–2010.

Depino, A. M. (2013). Peripheral and central inflammation in autism spectrum disorders. Molecular and Cellular Neuroscience, 53, 69–76.

Dietz, P. M., Rose, C. E., McArthur, D., & Maenner, M. (2020). National and state estimates of adults with autism spectrum disorder. Journal of Autism and Developmental Disorders, 50(1), 4258–4266.

Essa, M. M., Braidy, N., Vijayan, K. R., Subash, S., & Guillemin, G. J. (2013). Excitotoxicity in the pathogenesis of autism. Neurotoxicology Research, 23(4), 393–400.

Fredriksson, A., Stigsdotter, I. M., Hurtig, A., Ewalds-Kvist, B., & Archer, T. (2011). Running wheel activity restores MPTP-induced functional deficits. Journal of Neural Transmission, 118, 407–420.

Garay, P. A., & McAllister, A. K. (2010). Novel roles for immune molecules in neural development: Implications for neurodevelopmental disorders. Frontiers in Synaptic Neuroscience, 2, 136.

Garcia, K. L., Yu, G., Nicolini, C., Michalski, B., Garzon, D. J., Chiu, V. S., Tongiorgi, E., Szatmari, P., & Fahnestock, M. (2012). Altered balance of proteolytic isoforms of pro-brain-derived neurotrophic factor in autism. Journal of Neuropathology & Experimental Neurology, 71, 289–297.

Goines, P., & Van de Water, J. (2010). The immune system’s role in the biology of autism. Current Opinion in Neurology, 23, 111–117.

Green, H. F., Treacy, E., Keohane, A. K., Sullivan, A. M., O’Keeffe, G. W., & Nolan, Y. M. (2012). A role for interleukin-1β in determining the lineage fate of embryonic rat hippocampal neural precursor cells. Molecular and Cellular Neuroscience, 49, 311–321.

Guloksuz, S. A., Abali, O., Aktas Cetin, E., et al. (2017). Elevated plasma concentrations of S100 calcium‐binding protein B and tumor necrosis factor alpha in children with autism spectrum disorders. Revista Brasileira de Psiquiatria, 39(3), 195–200.

Hurley, L. L., & Tizabi, Y. (2013). Neuroinflammation, neurodegeneration, and depression. Neurotoxicology Research, 23(2), 131–144.

Inga Jácome, M. C., Morales Chacòn, L. M., Vera Cuesta, H., et al. (2016). Peripheral inflammatory markers contributing to comorbidities in autism. Behavioral Sciences, 6(4), 29.

Kalkbrenner, A. E., Daniels, J. L., Chen, J. C., Poole, C., Emch, M., & Morrissey, J. (2010). Perinatal exposure to hazardous air pollutants and autism spectrum disorders at age 8. Epidemiology, 21, 631–641.

Leonard, B., & Maes, M. (2012). Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways play a role in unipolar depression. Neuroscience & Biobehavioral Reviews, 36, 764–785.

Li, X., Chauhan, A., Sheikh, A. M., et al. (2009). Elevated immune response in the brain of autistic patients. Journal of Neuroimmunology, 207(1–2), 111–116.

Li, X., Chauhan, A., Sheikh, A. M., Patil, S., Chauhan, V., Li, X. M., Ji, L., Brown, T., & Malik, M. (2009). Elevated immune response in the brain of autistic patients. Journal of Neuroimmunology, 207, 111–116.

Lintas, C., Sacco, R., & Persico, A. M. (2012). Genome-wide expression studies in autism spectrum disorder, Rett syndrome, and Down syndrome. Neurobiology of Disease, 45, 57–68.

Maenner, M. J., Warren, Z., Williams, A. R., Amoakohene, E., Bakian, A. V., et al. (2023). Prevalence and characteristics of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network. MMWR Surveillance Summaries, 72(2), 1–14.

McAllister, A. K., & Van de Water, J. (2009). Breaking boundaries in neural-immune interactions. Neuron, 64, 9–12.

Molloy, C. A., Morrow, A. L., Meinzen-Derr, J., et al. (2006). Elevated cytokine levels in children with autism spectrum disorder. Journal of Neuroimmunology, 172, 198–205.

Mostafa, G. A., & Al-Ayadhi, L. Y. (2011). The possible link between the elevated serum levels of neurokinin A and anti-ribosomal P protein antibodies in children with autism. Journal of Neuroinflammation, 8, 180.

Mostafa, G. A., Shehab, A. A., & Al-Ayadhi, L. Y. (2013). The link between some alleles on human leukocyte antigen system and autism in children. Journal of Neuroimmunology, 255(1–2), 70–74. https://doi.org/10.1016/j.jneuroim.2012.10.002

Murray, P. S., & Holmes, P. V. (2011). An overview of brain-derived neurotrophic factor and implications for excitotoxic vulnerability in the hippocampus. International Journal of Peptides. https://doi.org/10.1155/2011/654085

Müller, N., & Schwarz, M. J. (2007). The immune-mediated alteration of serotonin and glutamate: Towards an integrated view of depression. Molecular Psychiatry, 12, 988–1000.

Onore, C., Careaga, M., & Ashwood, P. (2012). The role of immune dysfunction in the pathophysiology of autism. Brain, Behavior, and Immunity, 26, 383–392.

Pardo, C. A., Farmer, C. A., Thurm, A., et al. (2017). Serum and cerebrospinal fluid immune mediators in children with autistic disorder: A longitudinal study. Molecular Autism, 8, 1–14.

Pardo, C. A., Vargas, D. L., & Zimmerman, A. W. (2005). Immunity, neuroglia and neuroinflammation in autism. International Review of Psychiatry, 17, 485–495.

Pucak, M. L., Carroll, K. A., Kerr, D. A., & Kaplin, A. I. (2007). Neuropsychiatric manifestations of depression in multiple sclerosis. Dialogues in Clinical Neuroscience, 9, 125–139.

Ricci, S., Fuso, A., Ippoliti, F., & Businaro, R. (2012). Stress-induced cytokines and neuronal dysfunction in Alzheimer’s disease. Journal of Alzheimer’s Disease, 28, 11–24.

Rook, G. A., Lowry, C. A., & Raison, C. L. (2011). Lymphocytes in neuroprotection, cognition and emotion: Is intolerance really the answer? Brain, Behavior, and Immunity, 25, 591–601.

Saghazadeh, A., Ataeinia, B., Keynejad, K., Abdolalizadeh, A., Hirbod‐Mobarakeh, A., & Rezaei, N. (2019). A meta‐analysis of pro‐inflammatory cytokines in autism spectrum disorders: Effects of age, gender, and latitude. Journal of Psychiatric Research, 115, 90–102.

Sokol, D. K., Chen, D., Farlow, M. R., et al. (2006). High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression. Journal of Child Neurology, 21, 444–449.

Tafolla, M., Singer, H., & Lord, C. (2025). Autism spectrum disorder across the lifespan. Annual Review of Clinical Psychology, 21, 193–220. https://doi.org/10.1146/annurev-clinpsy-081423-031110

Weinstein, A. A., Deuster, P. A., Francis, J. L., Bonsall, R. W., Tracy, R. P., & Kop, W. J. (2010). Neurohormonal and inflammatory hyper-responsiveness to acute mental stress in depression. Biological Psychology, 84, 228–234.

Xie, J., Huang, L., Li, X., et al. (2017). Immunological cytokine profiling identifies TNF‐α as a key molecule dysregulated in autistic children. Molecular Autism, 8, 47.

Ziats, M. N., & Rennert, O. M. (2011). Expression profiling of autism candidate genes during human brain development implicates central immune signaling pathways. PLoS ONE, 6, e24691.

Zunszain, P. A., Anacker, C., Cattaneo, A., Carvalho, L. A., & Pariante, C. M. (2011). Glucocorticoids, cytokines and brain abnormalities in depression. Progress in Neuropsychopharmacology & Biological Psychiatry, 35, 722–729.